Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 2002; Volume 61,Issue 2

Accelerated Communications

  • You have access
    Specific Recognition of the Bicyclic Pyrimidine Nucleoside Analogs, a New Class of Highly Potent and Selective Inhibitors of Varicella-Zoster Virus (VZV), by the VZV-Encoded Thymidine Kinase
    Rebecca Sienaert, Lieve Naesens, Andrea Brancale, Erik De Clercq, Christopher McGuigan and Jan Balzarini
    Molecular Pharmacology February 2002, 61 (2) 249-254; DOI: https://doi.org/10.1124/mol.61.2.249
  • You have access
    Identification of a Novel Dioxin-Inducible Cytochrome P450
    Steven P. Rivera, Sirkku T. Saarikoski and Oliver Hankinson
    Molecular Pharmacology February 2002, 61 (2) 255-259; DOI: https://doi.org/10.1124/mol.61.2.255
  • You have access
    Secretory Peptide Hormones Are Biochemical Antioxidants: Structure-Activity Relationship
    Bernd Moosmann and Christian Behl
    Molecular Pharmacology February 2002, 61 (2) 260-268; DOI: https://doi.org/10.1124/mol.61.2.260
  • You have access
    Apolipoprotein B mRNA Editing and the Reduction in Synthesis and Secretion of the Atherogenic Risk Factor, Apolipoprotein B100 Can Be Effectively Targeted through TAT-Mediated Protein Transduction
    Yan Yang, Nazzareno Ballatori and Harold C. Smith
    Molecular Pharmacology February 2002, 61 (2) 269-276; DOI: https://doi.org/10.1124/mol.61.2.269

Articles

  • You have access
    Molecular Mechanism for Endothelin-1–Induced Stress-Fiber Formation: Analysis of G Proteins Using a Mutant EndothelinA Receptor
    Yoshifumi Kawanabe, Yasuo Okamoto, Kazuhiko Nozaki, Nobuo Hashimoto, Soichi Miwa and Tomoh Masaki
    Molecular Pharmacology February 2002, 61 (2) 277-284; DOI: https://doi.org/10.1124/mol.61.2.277
  • You have access
    Modulation of Kv1.5 Currents by Protein Kinase A, Tyrosine Kinase, and Protein Tyrosine Phosphatase Requires an Intact Cytoskeleton
    H. S. Mason, M. J. Latten, L. D. Godoy, B. Horowitz and J. L. Kenyon
    Molecular Pharmacology February 2002, 61 (2) 285-293; DOI: https://doi.org/10.1124/mol.61.2.285
  • You have access
    The Possible Implication of trans-Resveratrol in the Cardioprotective Effects of Long-Term Moderate Wine Consumption
    Francisco Orallo, Ezequiel Álvarez, Mercedes Camiña, José Manuel Leiro, Eva Gómez and Pilar Fernández
    Molecular Pharmacology February 2002, 61 (2) 294-302; DOI: https://doi.org/10.1124/mol.61.2.294
  • You have access
    Conserved Cysteine Residues in the Extracellular Loop of the Human P2X1 Receptor Form Disulfide Bonds and Are Involved in Receptor Trafficking to the Cell Surface
    Steven J. Ennion and Richard J. Evans
    Molecular Pharmacology February 2002, 61 (2) 303-311; DOI: https://doi.org/10.1124/mol.61.2.303
  • You have access
    Phosphorylation of Blood Vessel Vasodilator-Stimulated Phosphoprotein at Serine 239 as a Functional Biochemical Marker of Endothelial Nitric Oxide/Cyclic GMP Signaling
    César Ibarra-Alvarado, Jan Galle, Volker O. Melichar, Alexander Mameghani and Harald H. H. W. Schmidt
    Molecular Pharmacology February 2002, 61 (2) 312-319; DOI: https://doi.org/10.1124/mol.61.2.312
  • You have access
    Differential Gene Expression of NAD(P)H:Quinone Oxidoreductase and NRH:Quinone Oxidoreductase in Human Hepatocellular and Biliary Tissue
    Ahlke Strassburg, Christian P. Strassburg, Michael P. Manns and Robert H. Tukey
    Molecular Pharmacology February 2002, 61 (2) 320-325; DOI: https://doi.org/10.1124/mol.61.2.320
  • You have access
    NMDA Receptors Formed by NR1 in Xenopus laevisOocytes Do Not Contain the Endogenous Subunit XenU1
    Tim Green, Cheryl A. Rogers, Anis Contractor and Stephen F. Heinemann
    Molecular Pharmacology February 2002, 61 (2) 326-333; DOI: https://doi.org/10.1124/mol.61.2.326
  • You have access
    Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway
    Carlo J. Gambone, Juliet M. Hutcheson, Jerome L. Gabriel, Richard L. Beard, Roshantha A.S. Chandraratna, Kenneth J. Soprano and Dianne Robert Soprano
    Molecular Pharmacology February 2002, 61 (2) 334-342; DOI: https://doi.org/10.1124/mol.61.2.334
  • You have access
    Calcium-Independent Activation of Extracellularly Regulated Kinases 1 and 2 by Angiotensin II in Hepatic C9 Cells: Roles of Protein Kinase Cδ, Src/Proline-Rich Tyrosine Kinase 2, and Epidermal Growth Factor Receptor trans-Activation
    Bukhtiar H. Shah and Kevin J. Catt
    Molecular Pharmacology February 2002, 61 (2) 343-351; DOI: https://doi.org/10.1124/mol.61.2.343
  • You have access
    Real-Time Visualization of a Fluorescent Gαs: Dissociation of the Activated G Protein from Plasma Membrane
    Jiang-Zhou Yu and Mark M. Rasenick
    Molecular Pharmacology February 2002, 61 (2) 352-359; DOI: https://doi.org/10.1124/mol.61.2.352
  • You have access
    Modulation of Neuroleptic Activity of 9,10-Didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline Bimaleinate (LEK-8829) by D1 Intrinsic Activity in Hemi-Parkinsonian Rats
    Gordana Glavan, Dus̆an Sket and Marko Z̆ivin
    Molecular Pharmacology February 2002, 61 (2) 360-368; DOI: https://doi.org/10.1124/mol.61.2.360
  • You have access
    Protons Enhance the Gating Kinetics of the α3/β4 Neuronal Nicotinic Acetylcholine Receptor by Increasing Its Apparent Affinity to Agonists
    Galya Abdrakhmanova, Julia Dorfman, Yingxian Xiao and Martin Morad
    Molecular Pharmacology February 2002, 61 (2) 369-378; DOI: https://doi.org/10.1124/mol.61.2.369
  • You have access
    Reciprocal Regulation of β1-Adrenergic Receptor Gene Transcription by Sp1 and Early Growth Response Gene 1: Induction of EGR-1 Inhibits the Expression of the β1-Adrenergic Receptor Gene
    Suleiman W. Bahouth, Michael J. Beauchamp and Kim N. Vu
    Molecular Pharmacology February 2002, 61 (2) 379-390; DOI: https://doi.org/10.1124/mol.61.2.379
  • You have access
    Binding Characteristics of Cetirizine and Levocetirizine to Human H1 Histamine Receptors: Contribution of Lys191and Thr194
    Michel Gillard, Christy Van Der Perren, Nicole Moguilevsky, Roy Massingham and Pierre Chatelain
    Molecular Pharmacology February 2002, 61 (2) 391-399; DOI: https://doi.org/10.1124/mol.61.2.391
  • You have access
    Chimeric Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Reverse Transcriptases: Role of the Subunits in Resistance/Sensitivity to Non-Nucleoside Reverse Transcriptase Inhibitors
    Joeri Auwerx, Thomas W. North, Bradley D. Preston, George J. Klarmann, Erik De Clercq and Jan Balzarini
    Molecular Pharmacology February 2002, 61 (2) 400-406; DOI: https://doi.org/10.1124/mol.61.2.400
  • You have access
    Interaction of KATP Channel Modulators with Sulfonylurea Receptor SUR2B: Implication for Tetramer Formation and Allosteric Coupling of Subunits
    Cornelia Löffler-Walz, Annette Hambrock and Ulrich Quast
    Molecular Pharmacology February 2002, 61 (2) 407-414; DOI: https://doi.org/10.1124/mol.61.2.407
  • You have access
    A3 Adenosine Receptors in Human Neutrophils and Promyelocytic HL60 Cells: A Pharmacological and Biochemical Study
    Stefania Gessi, Katia Varani, Stefania Merighi, Elena Cattabriga, Valeria Iannotta, Edward Leung, Pier Giovanni Baraldi and Pier Andrea Borea
    Molecular Pharmacology February 2002, 61 (2) 415-424; DOI: https://doi.org/10.1124/mol.61.2.415
  • You have access
    The Thiol Sensitivity of Glutathione Transport in Sidedness-Sorted Basolateral Liver Plasma Membrane and in Oatp1-Expressing HeLa Cell Membrane
    Aravind Mittur, Allan W. Wolkoff and Neil Kaplowitz
    Molecular Pharmacology February 2002, 61 (2) 425-435; DOI: https://doi.org/10.1124/mol.61.2.425
  • You have access
    Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane
    Karley Y. Little, Lawrence W. Elmer, Huailing Zhong, Joshua O. Scheys and Lian Zhang
    Molecular Pharmacology February 2002, 61 (2) 436-445; DOI: https://doi.org/10.1124/mol.61.2.436
  • You have access
    Cannabinol Enhancement of Interleukin-2 (IL-2) Expression by T Cells Is Associated with an Increase in IL-2 Distal Nuclear Factor of Activated T Cell Activity
    Tong-Rong Jan, Gautham K. Rao and Norbert E. Kaminski
    Molecular Pharmacology February 2002, 61 (2) 446-454; DOI: https://doi.org/10.1124/mol.61.2.446
  • You have access
    Human A2A Adenosine Receptors: High-Affinity Agonist Binding to Receptor-G Protein Complexes Containing Gβ4
    Lauren J. Murphree, Melissa A. Marshall, Jayson M. Rieger, Timothy L. MacDonald and Joel Linden
    Molecular Pharmacology February 2002, 61 (2) 455-462; DOI: https://doi.org/10.1124/mol.61.2.455
  • You have access
    Mapping the Agonist Binding Site of the Nicotinic Acetylcholine Receptor by Cysteine Scanning Mutagenesis: Antagonist Footprint and Secondary Structure Prediction
    Deirdre Sullivan, David C. Chiara and Jonathan B. Cohen
    Molecular Pharmacology February 2002, 61 (2) 463-472; DOI: https://doi.org/10.1124/mol.61.2.463
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 61 (2)
Molecular Pharmacology
Vol. 61, Issue 2
1 Feb 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics